Plasma lipidomics of primary biliary cholangitis and its comparison with Sjögren’s syndrome

BackgroundAbnormal lipid metabolism is common in patients with primary biliary cholangitis (PBC). PBC and Sjögren’s syndrome (SS) frequently coexist in clinical practice; however, the lipid characteristics of both diseases are unknown. Therefore, we aimed to analyze the plasma lipid profiles of both...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Haolong Li, Haoting Zhan, Linlin Cheng, Yuan Huang, Xiaomeng Li, Songxin Yan, Yongmei Liu, Li Wang, Yongzhe Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Subjects:	lipidomics primary biliary cholangitis Sjögren’s syndrome plasma ursodeoxycholic acid
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1124443/full

Similar Items

Primary biliary cholangitis
by: I. M. Iljinsky, et al.
Published: (2021-04-01)

Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study
by: Jong-In Chang, et al.
Published: (2023-07-01)

Prognostic scores in primary biliary cholangitis
by: Ramzi Tababi, et al.
Published: (2024-12-01)

Obeticholic Acid for Primary Biliary Cholangitis
by: Annarosa Floreani, et al.
Published: (2022-10-01)

Pharmacotherapy for primary biliary cholangitis: an assessment of medication candidacy and rates of treatment
by: Nicholas MacDonald, et al.
Published: (2024-01-01)

Laboratory risk factors for coexistent primary biliary cholangitis in patients with Sjögren’s syndrome: a retrospective study
by: Xuan Gao, et al.
Published: (2023-06-01)

Machine learning prediction model for treatment responders in patients with primary biliary cholangitis
by: Naruhiro Kimura, et al.
Published: (2023-06-01)

Efficacy of ursodeoxycholic acid for primary biliary cholangitis: Experience from a tertiary care centre in Saudi Arabia
by: Ahmed H AlWabel, et al.
Published: (2023-01-01)

COVID-19 in Patients with Primary Biliary Cholangitis
by: М. К. Prashnova, et al.
Published: (2022-09-01)

Common pathological mechanisms and therapeutic strategies in primary Sjogren’s syndrome and primary biliary cholangitis: from tissue immune microenvironment to targeted therapy
by: Keying Ye, et al.
Published: (2025-09-01)

Prediction of poor response to ursodeoxycholic acid in patients with primary biliary cholangitis by non-invasive markers
by: Gao Lili, Pan Shida, Zhang Yijin, Gao Xuesong, Su Nan, Xu Li, Duan Xuefei
Published: (2023-02-01)

Quality of Life in Primary Biliary Cholangitis - Advances in the Treatment
by: Agnieszka Kuzio, et al.
Published: (2024-09-01)

Clinical and Biochemical Characteristics of a Danish and Turkish Cohort of Incident and Prevalent Patients with Primary Biliary Cholangitis
by: Hasan Eruzun, et al.
Published: (2025-04-01)

Optimal drug regimens for improving ALP biochemical levels in patients with primary biliary cholangitis refractory to UDCA: a systematic review and Bayesian network meta-analysis
by: Wei Lin, et al.
Published: (2024-01-01)

Current and future opportunities for the management of primary biliary cholangitis
by: Sandra Naffouj, et al.
Published: (2023-12-01)

The effectiveness of combining ursodeoxycholic acid with vitamin D in treating patients with primary biliary cholangitis and its impact on hepatic fibrosis: a randomized trial
by: Yilihamu Abulitifu, et al.
Published: (2025-07-01)

Early assessment of treatment response in primary biliary cholangitis: key to timely management
by: Tomas Koky, et al.
Published: (2025-08-01)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
by: Ji-Won Park, et al.
Published: (2022-05-01)

Clinical, Molecular, and Histopathological Aspect of Primary Biliary Cholangitis
by: Flora Dameria, et al.
Published: (2020-07-01)

Efficacy and Safety of Novel Oral Anti-Cholestatic Agents for Primary Biliary Cholangitis: Meta-Analyses and Systematic Review
by: Eyad Gadour, et al.
Published: (2025-05-01)

Curative effect of anti-fibrosis Chinese patent medicines combined with ursodeoxycholic acid for primary biliary cholangitis: A systematic review and meta-analysis
by: Yufei Bi, et al.
Published: (2023-03-01)

Acceptance, safety, and immunogenicity of a booster dose of inactivated SARS-CoV-2 vaccine in patients with primary biliary cholangitis
by: Haolong Li, et al.
Published: (2024-04-01)

Extrahepatic Manifestations of Primary Biliary Cholangitis
by: Sara L Chalifoux, et al.
Published: (2017-11-01)

Animal models of primary biliary cholangitis: status and challenges
by: Xu Wang, et al.
Published: (2023-11-01)

Correspondence to editorial on “Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive”
by: Haolong Li, et al.
Published: (2025-04-01)

Double-negative T cells in combination with ursodeoxycholic acid ameliorates immune-mediated cholangitis in mice
by: Chunpan Zhang, et al.
Published: (2025-04-01)

Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitis
by: Hong-Li Liu, et al.
Published: (2025-09-01)

Follicular cholangitis: a rare cause of benign biliary stricture
by: Virginia Lampropoulou, et al.
Published: (2023-11-01)

Impact of cholangitis on survival of patients with malignant biliary obstruction treated with percutaneous transhepatic biliary drainage
by: Jarmo Niemelä, et al.
Published: (2023-03-01)

Autoimmune liver damage in patients with primary Sjogren's syndrome associated with anticentromeric antibodies
by: B. D. Chalcev, et al.
Published: (2021-06-01)

Overlap syndrome of seronegative primary biliary cholangitis and small duct primary sclerosing cholangitis: a first case report and literature review
by: Salma Souissi, et al.
Published: (2024-12-01)

Primary Biliary Cholangitis with Ankylosing Spondylitis
by: Young Mi Hong, et al.
Published: (2022-06-01)

Cholesterol-modified prognostic nutritional index as an independent prognostic biomarker in primary biliary cholangitis patients
by: Huiling Zhu, et al.
Published: (2025-05-01)

Association of bile acid composition with synthetic pathways and efficacy of bezafibrate in cholestatic liver disease
by: Manami Iida, et al.
Published: (2025-10-01)

ACUTE CHOLANGITIS, COMPLICATED BY BILIARY SEPSIS: CLINICAL CASE WITH A FAVORABLE OUTCOME
by: I. G. Malakhova, et al.
Published: (2016-08-01)

Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort study
by: Rozanne C. de Veer, et al.
Published: (2024-08-01)

Ultrasound imaging findings in primary biliary cholangitis
by: Yuan Zhang, et al.
Published: (2023-12-01)

Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive
by: Haolong Li, et al.
Published: (2025-04-01)

Rare renal proximal tubular dysfunctions in primary biliary cholangitis
by: Xiaoxiao Shi, et al.
Published: (2024-12-01)

Retrospective screening of serum IgG glycosylation biomarker for primary Sjögren’s syndrome using lectin microarray
by: Siting Li, et al.
Published: (2023-02-01)